Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer.
about
Signatures derived from increase in SHARPIN gene copy number are associated with poor prognosis in patients with breast cancer.The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.MSP-4, an Antimicrobial Peptide, Induces Apoptosis via Activation of Extrinsic Fas/FasL- and Intrinsic Mitochondria-Mediated Pathways in One Osteosarcoma Cell Line.Integrative (epi) Genomic Analysis to Predict Response to Androgen-Deprivation Therapy in Prostate Cancer.
P2860
Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting FOSB with a cationic ...... triple-negative breast cancer.
@en
Targeting FOSB with a cationic ...... triple-negative breast cancer.
@nl
type
label
Targeting FOSB with a cationic ...... triple-negative breast cancer.
@en
Targeting FOSB with a cationic ...... triple-negative breast cancer.
@nl
prefLabel
Targeting FOSB with a cationic ...... triple-negative breast cancer.
@en
Targeting FOSB with a cationic ...... triple-negative breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Targeting FOSB with a cationic ...... triple-negative breast cancer.
@en
P2093
Chang-Jer Wu
Chen-Hung Ting
Jyh-Yih Chen
Yi-Chun Chen
P2860
P304
40329-40347
P356
10.18632/ONCOTARGET.9612
P407
P577
2016-05-26T00:00:00Z